As much as $135 million in value will be unlocked as stock of five companies eligible for trading as their shareholder ...

Reddy’s is selling a portfolio of 14 Abbreviated New Drug Applications to Ahmedabad-based Senores Pharmaceuticals ... through proceeds from its IPO, the report noted. The acquired portfolio ...

This is in line with the objects of the IPO stated in the Red Herring Prospectus. Commenting on the acquisition, Swapnil Shah, managing director, Senores Pharmaceuticals said: “We are glad to announce ...

Shares of Senores Pharmaceuticals Ltd jumped 7.25 percent ... The acquisition will be funded through the Initial Public Offer (IPO) proceeds raised by Senores Pharma. This is in line with the ...

Trading volumes of all these stocks were higher than average, as shares allotted to anchor investors ahead of their IPO ...

Senores Pharmaceuticals Ltd, a pharmaceutical formulations manufacturer that made its stock market debut in December last year, plans to focus on product acquisitions to expand its pipeline, a top ...

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December. The portfolio of products acquired includes controlled ...

Senores Pharmaceuticals Limited was originally incorporated ... The Company is planning to raise money from public through IPO by issue and allotment of 2,700,000 Equity Shares through Offer ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Senores Pharmaceuticals Ltd announced on Tuesday the acquisition of 14 Abbreviated New Drug Applications (ANDAs) from Dr Reddy’s Laboratories through its wholly owned US subsidiary. The shares ...

Senores Pharmaceuticals Limited has informed the Exchange regarding investment through rights issue in Senores Pharmaceuticals Inc., Wholly Owned Subsidiary of the Company. Senores Pharmaceutic ...